B
LEGN icon

Braidwell’s Legend Biotech LEGN Stock Holding History

Braidwell’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,298,142
Closed -$28.2M – 95
2025
Q4 		$28.2M Sell
1,298,142
-528,013
-29% -$15.1M 0.9% 44
2025
Q3 		$59.6M Sell
1,826,155
-715,949
-28% -$26.4M 1.77% 18
2025
Q2 		$90.2M Sell
2,542,104
-435,847
-15% -$14.1M 3.09% 10
2025
Q1 		$101M Hold
2,977,951
– – 3.55% 4
2024
Q4 		$96.9M Buy
2,977,951
+1,436,400
+93% +$59.5M 2.87% 9
2024
Q3 		$75.1M Sell
1,541,551
-128,169
-8% -$6.83M 2.13% 16
2024
Q2 		$74M Buy
1,669,720
+425,925
+34% +$19.6M 2.32% 14
2024
Q1 		$69.8M Buy
1,243,795
+681,195
+121% +$41.1M 2.25% 12
2023
Q4 		$33.9M Sell
562,600
-316,964
-36% -$20.1M 1.24% 32
2023
Q3 		$59.1M Buy
879,564
+323,263
+58% +$22.5M 1.87% 12
2023
Q2 		$38.4M Sell
556,301
-45,500
-8% -$2.97M 1.25% 29
2023
Q1 		$29M Sell
601,801
-56,300
-9% -$2.75M 0.96% 40
2022
Q4 		$32.9M Buy
+658,101
New +$31.9M 1.1% 34

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Braidwell's LEGN Position: Q1 2026 in Review

Braidwell sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 1,298,142 shares — an estimated $28.2M sold.

Braidwell first reported a position in LEGN in Q4 2022 and held it in 13 quarters. The position peaked at $101M in Q1 2025. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Braidwell reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Braidwell sold 1,298,142 Legend Biotech shares in Q1 2026, an estimated $28.2M.
  • Braidwell first reported a position in Legend Biotech in Q4 2022 and held it in 13 quarters.
  • Braidwell's Legend Biotech position peaked at $101M in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Braidwell's 13F filing for Q1 2026, filed 15 May 2026.